4-AcO-DMT: Difference between revisions
>Josikins No edit summary |
>Josikins No edit summary |
||
Line 29: | Line 29: | ||
=Pharmacology= | =Pharmacology= | ||
Psilacetin acts as a 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub> and 5-HT<sub> | Psilacetin acts as a [[Serotonin#The_5-HT_System|5-HT<sub>1A</sub>]], 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>, 5-HT<sub>5</sub> and 5-HT<sub>6</sub> [[Agonist#Agonists|partial agonist]]. The psychedelic effects are believed to come from LSD's efficacy at the 5-HT<sub>2A</sub> receptors. There is also efficacy at all [[Dopamine#The Dopamine System|dopamine receptors]] and all [[Adrenaline#The_Adrenergic_System|adrenoreceptors]]. | ||
In the body, psilacetin is thought to be deacetylated to psilocin during first pass metabolism and subsequent passes through the liver (evident as psilacetin is also active when injected). This has not been formally proven however and is based on reports that most users can not tell the difference between these two compounds when ingested to the point that they are often considered as indistinguishable from each other in terms of their subjective effects. | In the body, psilacetin is thought to be deacetylated to psilocin during first pass metabolism and subsequent passes through the liver (evident as psilacetin is also active when injected). This has not been formally proven however and is based on reports that most users can not tell the difference between these two compounds when ingested to the point that they are often considered as indistinguishable from each other in terms of their subjective effects. |